Two Diseases with One Hit: Inhibiting a Potential Diabetes Target to Reduce Cancer Risk and to Improve Anti-Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|5|2|111-121

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.5, Iss.2, 2009-05, pp. : 111-121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucuronides in Anti-Cancer Therapy

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 2, 2003-03 ,pp. : 139-150

Bentham Science Publishers

Access to resources Recommend Favorite

Doxycycline as Potential Anti-cancer Agent

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 12, 2018-01 ,pp. : 1617-1623

Bentham Science Publishers

Access to resources Recommend Favorite

The HOX Gene Network as a Potential Target for Cancer Therapy

By  

Current Cancer Therapy Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 17-24

Bentham Science Publishers

Access to resources Recommend Favorite

CYP24A1 as a Potential Target for Cancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 97-108

Bentham Science Publishers

Access to resources Recommend Favorite

Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 6, 2012-07 ,pp. : 678-685

Bentham Science Publishers

Access to resources Recommend Favorite